Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders.
Konen FF, Möhn N, Witte T, Schefzyk M, Wiestler M, Lovric S, Hufendiek K, Schwenkenbecher P, Sühs KW, Friese MA, Klotz L, Pul R, Pawlitzki M, Hagin D, Kleinschnitz C, Meuth SG, Skripuletz T. Konen FF, et al. Among authors: schwenkenbecher p. Autoimmun Rev. 2023 May;22(5):103312. doi: 10.1016/j.autrev.2023.103312. Epub 2023 Mar 15. Autoimmun Rev. 2023. PMID: 36924922 Free article. Review.
[Performance of the revised 2017 McDonald criteria].
Konen FF, Schwenkenbecher P, Wattjes MP, Skripuletz T. Konen FF, et al. Among authors: schwenkenbecher p. Nervenarzt. 2023 Jun;94(6):538-545. doi: 10.1007/s00115-022-01410-2. Epub 2022 Dec 1. Nervenarzt. 2023. PMID: 36454262 Free PMC article. Review. German.
Saliva Free Light Chains in Patients with Neuro-Sjögren.
Konen FF, Seeliger T, Schwenkenbecher P, Gingele S, Jendretzky KF, Sühs KW, Ernst D, Witte T, Skripuletz T. Konen FF, et al. Among authors: schwenkenbecher p. Biomedicines. 2022 Oct 3;10(10):2470. doi: 10.3390/biomedicines10102470. Biomedicines. 2022. PMID: 36289732 Free PMC article.
Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial - Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial.
Huehnchen P, Bangemann N, Lischewski S, Märschenz S, Paul F, Schmitz-Hübsch T, Blohmer JU, Eberhardt C, Rauch G, Flöel A, Adam S, Schwenkenbecher P, Meinhold-Heerlein I, Hoffmann O, Ziemssen T, Endres M, Boehmerle W. Huehnchen P, et al. Among authors: schwenkenbecher p. Front Med (Lausanne). 2022 Aug 11;9:967964. doi: 10.3389/fmed.2022.967964. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36035422 Free PMC article.
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis.
Konen FF, Hannich MJ, Schwenkenbecher P, Grothe M, Gag K, Jendretzky KF, Gingele S, Sühs KW, Witte T, Skripuletz T, Süße M. Konen FF, et al. Among authors: schwenkenbecher p. Biomedicines. 2022 Jul 7;10(7):1629. doi: 10.3390/biomedicines10071629. Biomedicines. 2022. PMID: 35884934 Free PMC article.
50 results